APA
Tofte N., Lindhardt M., Adamova K., Beige J., Beulens J. W. J., Birkenfeld A. L., Currie G., Delles C., Dimos I., Francová L., Frimodt-Møller M., Girman P., Göke R., Havrdova T., Kooy A., Mischak H., Navis G., Nijpels G., Noutsou M., Ortiz A., Parvanova A., Persson F., Ruggenenti P. L., Rutters F., Rychlík I., Spasovski G., Speeckaert M., Trillini M., von der Leyen H. & Rossing P. (20190128). Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes. : Diabetic medicine : a journal of the British Diabetic Association.
Chicago
Tofte N, Lindhardt M, Adamova K, Beige J, Beulens J W J, Birkenfeld A L, Currie G, Delles C, Dimos I, Francová L, Frimodt-Møller M, Girman P, Göke R, Havrdova T, Kooy A, Mischak H, Navis G, Nijpels G, Noutsou M, Ortiz A, Parvanova A, Persson F, Ruggenenti P L, Rutters F, Rychlík I, Spasovski G, Speeckaert M, Trillini M, von der Leyen H and Rossing P. 20190128. Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes. : Diabetic medicine : a journal of the British Diabetic Association.
Harvard
Tofte N., Lindhardt M., Adamova K., Beige J., Beulens J. W. J., Birkenfeld A. L., Currie G., Delles C., Dimos I., Francová L., Frimodt-Møller M., Girman P., Göke R., Havrdova T., Kooy A., Mischak H., Navis G., Nijpels G., Noutsou M., Ortiz A., Parvanova A., Persson F., Ruggenenti P. L., Rutters F., Rychlík I., Spasovski G., Speeckaert M., Trillini M., von der Leyen H. and Rossing P. (20190128). Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes. : Diabetic medicine : a journal of the British Diabetic Association.
MLA
Tofte N, Lindhardt M, Adamova K, Beige J, Beulens J W J, Birkenfeld A L, Currie G, Delles C, Dimos I, Francová L, Frimodt-Møller M, Girman P, Göke R, Havrdova T, Kooy A, Mischak H, Navis G, Nijpels G, Noutsou M, Ortiz A, Parvanova A, Persson F, Ruggenenti P L, Rutters F, Rychlík I, Spasovski G, Speeckaert M, Trillini M, von der Leyen H and Rossing P. Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes. : Diabetic medicine : a journal of the British Diabetic Association. 20190128.